Possible scenario
Real Funding Expansion
30% Chance
The announcement becomes the opening bid for a more substantive federal initiative, helped by bipartisan pressure over uterine cancer deaths, ovarian longevity research, and documented women’s health underfunding. Congress and NIH create new requests for applications in cancer, cardiovascular disease, autoimmune disease, fertility, and menopause.
Secondary impacts
- Healthcare +1.3%
- Business Services +0.5%
- Technology +0.2%
Tickers
- MYGN+3.9%
- ILMN+1.4%
- OGN+1.4%
- +0.8%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.